The effect of dopaminergic medication on force fluctuation in Parkinson’s disease
Objective: To quantify and compare muscle force variability during isometric dorsiflexion in male patients with Parkinson's Disease (PD), in the ON- versus OFF-medication state. Background:…Therapy-associated risk decision making in individuals with multiple system atrophy and Parkinson’s disease, THE YAMSA TRIAL
Objective: This study aimed to quantify the risk willingness of patients suffering from the α-synucleinopathies multiple system atrophy (MSA) and Parkinson's Disease (PD) and identify…The Roche ‘End-to-End Matrix’ for Patient-Centric Drug Discovery and Development – Focus on Parkinson’s disease
Objective: To develop an ‘End-to-End Matrix’ for Patient-Centric Drug Discovery and Development to increase the probability of success of clinical trials in Parkinson’s disease. Background:…Cortical gamma oscillations in Parkinson’s disease: ipsi- and contralateral deep brain stimulation-induced entrainment
Objective: To characterize deep brain stimulation (DBS) parameters for bilateral induction of cortical finely tuned gamma (FTG) via unilateral stimulation. Background: FTG oscillations are reported…Cholinergic subtyping in Parkinson disease: differential 2-year interval changes
Objective: To investigate 2-yr interval change in cholinergic transporters in biology-based cholinergic subgroups using serial VAChT [18F]FEOBV brain PET in Parkinson’s disease (PD). Background: Current…Investigation of superficial brain stimulation (SBS) in Parkinsonian rats as a non-invasive alternative treatment for patients with movement disorders
Objective: To investigate repetitive transcranial magnetic stimulation (rTMS) in parkinsonian rats as a non-invasive, malleable superficial brain stimulation (SBS) alternative to DBS. Background: DBS is…Pain and sleep in Parkinson’s disease
Objective: Pain and sleep disturbances are among the most frequently encountered non-motor symptoms in Parkinson’s disease (PD). Background: The aim of this study was to…Gluten-free diet in Parkinson’s disease patients – feasibility, safety and preliminary results
Objective: The primary objective of this project is to evaluate the effect of long administered gluten-free diet (GFD) on motor symptoms of Parkinson's disease (PD).…How helpful is the Swallow tail sign in Parkinson’s disease?
Objective: To report a patient diagnosed with idiopathic Parkinson’s disease (PD) with an intact Swallow tail sign (STS) shown in his MR susceptibility-weighted imaging (SWI)…Differences in patients with Impulse Control Disorder based on antiparkinsonian drug treatment in a Mexican Institute.
Objective: To describe the differences in multiple factors based on Parkinson's treatment in patients with impulse control disorder Background: In intermediate-advanced phases of PE, psychiatric…
- « Previous Page
- 1
- …
- 116
- 117
- 118
- 119
- 120
- …
- 338
- Next Page »